Today's Top Stocks: HSIC, Moderna, Uber And More
Date
11/23/2024 6:42:05 AM
(MENAFN- Baystreet)
After trading in a range at around $70.00, Henry Schein (HSIC) jumped by 7.46% on Monday. The firm attracted investor attention last week after Nomura said it bought 1.02 million HSIC shares.
HSIC must break out of its 5-year trading range of $70 - $75 before it attracts long-term investors. The stock did not reward long-term investors, nor did it pay a dividend.
After a steep selloff last week, Moderna (MRNA) may attract bottom-fishers. MRNA stock gained 7.22% yesterday when Piper Sandler said the stock has an attractive entry point. The firm has two products in its pipeline. The firm may post clinical data for mRNA-1647, a vaccine for Cytomegalovirus (“CMV”) within the next few months. mRNA-4157 and Keytruda is a personalized cancer vaccine that has promise.
Uber Technologies (UBER) is stuck in a downtrend. Hedge funds like David Tepper's Appaloosa sold 6% of its position. It is now holding 1.4 million shares. Dan Loeb's Third Point closed its position in the ride-hailing company. For investors who want to take a contrarian position, UBER is a potential rival to Tesla's Cybercab.
In the insurance segment, look at Root (ROOT). The stock bottomed out recently at $75 and closed at $95.49. In Q3, the firm reported earnings per share of $1.35.
MENAFN23112024000212011056ID1108917952
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.